Due to clinical similarities and overlaps in immunohistochemistry, including CD34 positivity, DFSPs must be differentiated from other benign and malignant lesions including, but not limited to, dermatofibromas, schwannomas, cutaneous neurofibromas, and solitary fibrous tumors (Table 1) [2]. The gene discussed is CD34; the disease is schwannoma.